For a long time, scientists have been searching for enzymes that can degrade commodity plastics such as Polyurethanes or poly-vinyl chloride (PVC). German-US company Covestro AG and researchers at University of Greifswald now say that they have found new enzymes that could do the job.
German Bayer AG opens first Co.Lab life science incubator in Cambridge/Boston. This comprises state-of-the-art laboratories and collaborative workspaces specifically designed to support entrepreneurs focused on developing cell and gene therapies.
Transmembrane proteins play a variety of roles in physiological processes such as protein ligation, recognition, transport, anchoring, and transduction.
An anti-TNF-antibody-cytokine fusion combo with chemotherapy turns inoperable brain tumours hot in mice. A Phase I trial sponsored by Philogen SpA is underway.
https://european-biotechnology.com/wp-content/uploads/2024/04/Glioblastoma_Christaras_A_wikimedia.com.jpeg778800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-05-25 07:27:002024-07-12 11:16:37Glioma drug combo turns tumours hot
The BioRN Life Science cluster Rhine-Neckar has set the right course to further accelerate the start-up dynamic. Several lighthouse projects have been established recently, fostering innovation and providing the ideal breeding ground for biotech projects. Joint forces now develop strategies to attract investors and increase the visibility of the start-up community. The Life Science Investors´ Day Heidelberg has established itself as a top-class platform.
https://european-biotechnology.com/wp-content/uploads/2024/04/_c__Ralphs_Fotos_pixabay.com.jpg9601280Uta Mommert/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngUta Mommert2023-05-24 09:13:162024-07-12 11:18:17VectivBio taken over in $1bn acquisition
2. BIOTECH CIRCLE – Almost twice as many visitors as at last year’s premiere were welcomed by Biotech Austria’s Chairman Peter Llewellyn-Davies in the Vienna Stock Exchange in April. Framed by a Flying Breakfast, the topic was the provocative question Science always wins?!
A new machine learning model can predict enzyme-substrate pairs, with an accuracy of over 90% and is ready to be used in pharmaceutical and industrial biotechnology.
The bioeconomy can be a major driver in bringing circularity, sustainability and competitive production to Europe as it aims towards becoming climate-neutral and more self-sufficient.
https://european-biotechnology.com/wp-content/uploads/2024/04/EB223_Dirk_Carrez_Intro_kl.jpg11822101Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-05-19 13:38:002024-12-03 09:00:57Building on the successes of Europe’s bioeconomy
https://european-biotechnology.com/wp-content/uploads/2024/04/Lanzatech.jpeg684960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-05-19 10:52:002024-07-12 11:21:41LanzaTech and Plastipak produce greener PET
Enzymatic plastic eaters
BackgroundFor a long time, scientists have been searching for enzymes that can degrade commodity plastics such as Polyurethanes or poly-vinyl chloride (PVC). German-US company Covestro AG and researchers at University of Greifswald now say that they have found new enzymes that could do the job.
Boston attracts Bayer
BackgroundGerman Bayer AG opens first Co.Lab life science incubator in Cambridge/Boston. This comprises state-of-the-art laboratories and collaborative workspaces specifically designed to support entrepreneurs focused on developing cell and gene therapies.
Membrane Proteins
Sponsored PublicationsTransmembrane proteins play a variety of roles in physiological processes such as protein ligation, recognition, transport, anchoring, and transduction.
Glioma drug combo turns tumours hot
Latest NewsAn anti-TNF-antibody-cytokine fusion combo with chemotherapy turns inoperable brain tumours hot in mice. A Phase I trial sponsored by Philogen SpA is underway.
Life Science ecosystem Rhine Neckar: Hot spot for investors
BackgroundThe BioRN Life Science cluster Rhine-Neckar has set the right course to further accelerate the start-up dynamic. Several lighthouse projects have been established recently, fostering innovation and providing the ideal breeding ground for biotech projects. Joint forces now develop strategies to attract investors and increase the visibility of the start-up community. The Life Science Investors´ Day Heidelberg has established itself as a top-class platform.
VectivBio taken over in $1bn acquisition
Latest NewsGI specialist Ironwood Pharmaceuticals Inc. has announced to acquire Swiss VectivBio Holding AG for $17 per share in an all-cash transaction.
Does science really always win?
Background2. BIOTECH CIRCLE – Almost twice as many visitors as at last year’s premiere were welcomed by Biotech Austria’s Chairman Peter Llewellyn-Davies in the Vienna Stock Exchange in April. Framed by a Flying Breakfast, the topic was the provocative question Science always wins?!
AI predicts an enzyme’s substrate
Latest NewsA new machine learning model can predict enzyme-substrate pairs, with an accuracy of over 90% and is ready to be used in pharmaceutical and industrial biotechnology.
Building on the successes of Europe’s bioeconomy
OpinionThe bioeconomy can be a major driver in bringing circularity, sustainability and competitive production to Europe as it aims towards becoming climate-neutral and more self-sufficient.
LanzaTech and Plastipak produce greener PET
Latest NewsCarbon-capture specialist LanzaTech Global and Plastipak Packaging Inc have produced the world’s first PET resin made from captured carbon emissions.